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Abstract 
 Tobacco use during pregnancy is one of the leading preventable causes of pregnancy 
complications and infant morbidity and mortality in the United States. Smoking before or during 
pregnancy can lead to an ectopic pregnancy, placental abruption, preterm birth, infant low birth 
weight, and even stillbirth. However, despite public awareness and education regarding the 
detrimental effects of tobacco use, more than 10 percent of women with a recent live birth 
reported smoking during pregnancy. Unfortunately, clinicians and health care providers seldom 
receive adequate and formal training on perinatal tobacco cessation. With minimal skills or 
knowledge regarding cessation strategies and behavioral counseling, limited progress has been 
made toward meeting national goals on perinatal tobacco use. This review explores interventions 
used within clinical settings that are designed to reduce tobacco use in the preconception, 
prenatal, and postpartum periods. Based on the review, evidence-based tools and resources were 
developed that can be used by health care providers to help clients quit the use of tobacco.  
Introduction 
 While the United States has seen a sharp decline in tobacco use since 1990, nearly one in 
five deaths, or an estimated 480,000 deaths annually, are due to tobacco related illnesses.1,2  
Often referred to as “one of the most preventable causes of disease, disability and death in the 
nation,”1 tobacco use is estimated to have cost the United States 5.1 million years of potential life 
lost and $96.8 billion in lost productivity per year.1 Tobacco use is linked to heart disease, stroke, 
lung disease, and numerous types of cancer.2 In fact, if tobacco use were to become obsolete, it is 
estimated that one in three cancer-related deaths in the United States could be avoided.3 It is 
important to note that this estimate does not take in account the potential cancer deaths from 
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environmental tobacco smoke or other types of tobacco use, including cigars, pipes, or smokeless 
tobacco.3 
  Each year, approximately 19.8 million women in the United States smoke.1 Like male 
smokers, women face unique health risks when using tobacco. While the main causes of 
smoking-related deaths among women are heart disease and lung cancer, tobacco use also has 
serious health effects on women’s reproductive health and function.4 Women who smoke are at 
increased risk for breast cancer, cervical cancer, ovarian cancer, infertility, and early 
menopause.1,4 Women of reproductive age (15-44 years) who smoke and pregnant women who 
smoke are more likely to suffer from adverse pregnancy complications and poor infant 
outcomes.1,4   
 The Pregnancy Risk Assessment Monitoring System (PRAMS), a federal program based 
out of the Centers for Disease Control and Prevention (CDC) and state health departments, 
collects data on maternal attitudes and experiences, including tobacco use before, during, and 
after pregnancy.5 According to the 2011 PRAMS, 10.7 percent of women with a recent live birth 
reported smoking in their third trimester of pregnancy.5 These rates vary widely by state, with 
some states reporting up to 30 percent of women continuing to smoke in the last 3 months of 
their pregnancy.1 Researchers note that fewer than half of those smoking during pregnancy report 
successfully quitting and remaining tobacco-free.1 It is important to note that data regarding 
successful cessation of tobacco use during pregnancy is considered to be inaccurate, as self-
report systems may lead to an overestimation.1 Furthermore, compared to non-pregnant women, 
pregnant women are less likely to disclose their smoking status due to stigmatization.1  
 Due to the immense, yet preventable, ramifications of perinatal tobacco use on maternal 
and child health, three Healthy People 2020 national health objectives were created to address 
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smoking before and during pregnancy.5 These objectives were set forth by the United States 
Department of Health and Human Services and include reducing the prevalence of female 
smoking before pregnancy to 14 percent; reducing the prevalence of cigarette smoking among 
pregnant women to 1.4 percent; and increasing the percentage of pregnant smokers who stop 
smoking during pregnancy to 30 percent.5 Please refer to Table 1 for national smoking rates 
surrounding pregnancy in relation to the Healthy People 2020 objectives.  
 
Table 1. U.S Women With Recent Live Birth Using Tobacco Before and During Pregnancy 
 Smoking 
Before 
Pregnancy 
Smoking 
During 
Pregnancy 
Quit Rates 
During 
Pregnancy 
Current National 
Rates5,6 
23.2% 10.7% 54.3% 
Healthy People 2020 
Objectives6 
14% 1.4% 30% 
          Sources: Healthy People 2020, PRAMS 2011 
 
 In addition to Healthy People 2020, the Affordable Care Act (ACA) has also made 
significant changes to prevention in healthcare, requiring all Medicaid programs to cover a 
comprehensive tobacco cessation benefit, including access to counseling and/or medications, for 
pregnant women without cost sharing.5 Eliminating these out of pocket costs for cessation 
treatments has been shown to be effective in smoking cessation.5 
 Due to a renewed focus on perinatal tobacco cessation, understanding best practices and 
efforts to reduce tobacco use among pregnant and non-pregnant women of reproductive age has 
become particularly pertinent for clinicians, health care providers, and public health 
professionals. 
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EPIDEMIOLOGY OF PERINATAL TOBACCO USE  
Smoking Before Pregnancy 
 According to 2011 PRAMS data, 23 percent of women with a recent live birth reported 
smoking 3 months before pregnancy.5 Approximately 55 percent of these women quit during 
their pregnancy; however, of those women, 40 percent relapsed within 6 months postpartum.5 
Using data from 40 PRAMS sites, the prevalence of women smoking before pregnancy did not 
change significantly from 2000-2010.5 In 2010, as a result of cultural and political differences, 
rates of women with a recent live birth that reported smoking during the 3 months before 
pregnancy ranged from 11.8 percent in Utah to 46.2 percent in West Virginia.5 New mothers 
with the highest prevalence of smoking before pregnancy were aged 20-24 years (34.7%), 
American Indian/Alaska Native (55.1%), had 12 years of education (32.6%), and had Medicaid 
coverage (34.4%).5 
Smoking During Pregnancy 
 As of 2011, 10.7 percent of women with a recent live birth in the United States reported 
using tobacco in the last three months of pregnancy.5 It is important to note that PRAMS data 
does not capture the prevalence of women who used tobacco during the first and second 
trimester but who quit before the last 3 months of pregnancy.5 While aggregated PRAMS data 
indicates a declining trend in tobacco use during pregnancy, rates during the study period varied 
significantly between states.5 States, such as Louisiana, Maine and Mississippi, saw an increase 
in the percentage of women smoking during pregnancy.5 Other states, such as Colorado, 
Minnesota, New Jersey and New York, saw a significant decline in tobacco use during 
pregnancy.5 Similarly to smoking before pregnancy, rates of women smoking during pregnancy 
varied substantially state to state, ranging from 2.3 percent in New York City to 30.5 percent in 
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West Virginia.5 New mothers with the highest prevalence of smoking during pregnancy were 20-
34 years of age (17.6%), American Indians/Alaska Natives (26%), had less than 12 years of 
education (17.6%), and had Medicaid coverage during pregnancy or at delivery (34.4%).5 
 As noted earlier, approximately 55 percent of new mothers reported quitting smoking by 
their last trimester of pregnancy, with quit rates ranging from 34.4 percent in West Virginia to 
74.6 percent in New York City.5 Women most likely to quit smoking during pregnancy were 
women who were younger than 20 years of age (59.3%), Asian/Pacific Islander (72.0%), had 
more than 12 years of education (65.7%), and had private insurance coverage during pregnancy 
or at delivery (68.2%). 5 
Smoking Postpartum  
 During the 2000-2010 study period, PRAMS data showed a significant decrease in the 
prevalence of women smoking after a live birth.5 Similarly to women smoking before and during 
pregnancy, rates ranged from 4.1 percent in New York City to 37.5 percent in West Virginia.5 In 
2010, aggregated data suggests that nearly 16 percent of women report smoking again at 
approximately 4 months postpartum.5 Women with the highest prevalence of smoking 
postpartum were 20–24 years of age (25.5%), American Indian/Alaska Native (40.1%), had 12 
years of education (24.5%), and had Medicaid coverage during pregnancy or delivery (24.3%).5 
Perinatal Tobacco Cessation Trends 
 During the 2000-2010 study period, PRAMS data indicated ‘moderate but significant’ 
decreases in the prevalence of women smoking during pregnancy and after delivery.5 However, 
smoking prevalence among women before pregnancy remained stagnant, and limited progress 
has been made toward reaching the Healthy People 2020 objectives in a majority of the PRAMS 
sites.5 While this is due to a multitude of complex factors, it is noteworthy to mention that 
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several states had defunded their tobacco cessation teams during this 2000-2010 period and 
instead, diverted their tobacco settlement money from tobacco control and treatment to other 
state activities.7  
Researchers suggest that if smoking prevalence continues to decline at its current pace 
(0.1 percentage per year), national goals for perinatal smoking cessation set forth by Healthy 
People 2020 will not be met for another 100 years.5 Consequently, Healthy People 2020 
encourages health care providers to approach perinatal smoking using a social determinants 
framework. By using a social determinants framework, clinicians are better able to recognize 
how social structural factors contribute to perinatal smoking and in turn, create more 
comprehensive cessation interventions.8 
SOCIAL DETERMINANTS OF HEALTH: WHO IS SMOKING AND WHY?  
 Social determinants of health are “conditions in the environment in which people are 
born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and 
quality-of-life outcomes and risks.”8 These conditions, consisting of social, economic, and 
physical elements, and their available resources can significantly influence health outcomes in 
communities.8 Healthy People 2020 has developed a “place-based” organizing framework that 
identifies five key areas of social determinants: economic stability (e.g. poverty, employment); 
education (e.g. high school graduation, language and literacy); social and community context 
(e.g. social cohesion, civic participation); health and health care (e.g. access to health care, health 
literacy); and neighborhood and built environment (e.g. access to healthy foods, quality of 
housing).8   
 These five types of social determinants can play a large role in women’s health and 
pregnancy outcomes. For instance, researchers note that compared to nonsmokers, women who 
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smoke before, during, or after pregnancy are typically of lower socioeconomic status with 12 or 
less years of education.5 These women are also more likely to be unmarried and have an annual 
income of less than $15,000.5 Socioeconomic status is noted to directly and indirectly influence 
major determinants of health, including health-care access and health behavior.9 Accordingly, 
women who smoke during their pregnancy are more likely to start prenatal care later, enroll in 
Medicaid, and receive WIC.5 Pregnancies are also often unintended and women who smoke are 
more likely to be first-time mothers.5    
 Smoking around the time of pregnancy is associated with social stress, low social 
support, material disadvantage and feelings of not being in control.10,11 Accordingly, a recent 
research study found that increased levels of depressive symptoms and stress are highly 
correlated with perinatal tobacco use among low-income women.11 Another study found that 
certain social variables, including limited support from peers and/or living with a partner who 
smokes, are associated with continued smoking during pregnancy.11 The same study found that 
relapsing postpartum is common when applying those same social variables to women who quit 
during pregnancy.11  
 Ockene et al. note that, “[these women]…portray an interesting constellation of 
addiction, life worries (including multiple children perhaps), and an environment that essentially 
reinforces continued smoking.”10 The authors suggest the smoking is rarely the only health 
challenge these women face during pregnancy and that women who smoke around the time of 
pregnancy may be facing other issues of greater urgency, including food and/or housing security, 
substance abuse, and domestic violence.10   For instance, one study found that self-reported 
neighborhood violence had a positive association with tobacco use in early pregnancy.11 In fact, 
scholars believe that smoking is increasingly becoming a coping mechanism for women in 
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resource-strapped social or environmental settings, and stress may be the trigger.12  These 
findings suggest that social determinants are critical to cessation interventions and must be taken 
into account when trying to modify women’s health behaviors.13 Unfortunately, social 
determinants affecting women’s smoking habits often go unmeasured or ignored.10,11 
MATERNAL AND INFANT HEALTH RISKS 
 Tobacco use during pregnancy is regarded as one of the few preventable causes 
associated with pregnancy complications and poor birth outcomes.1 In fact, women who quit 
smoking by the first trimester are likely to have healthy infants with weight and body 
measurements that are similar to infants born to women who do not smoke.14 However, without 
perinatal smoking cessation, smoking can cause detrimental effects by the third trimester of 
pregnancy.14 Thus, having identified perinatal smoking as a major public health problem, 
scholars have extensively researched maternal and infant health risks associated with tobacco use 
before, during and after pregnancy.1  
 Smoking prior to pregnancy has been shown to negatively affect women’s reproductive 
health. Women who smoke prior to pregnancy not only have reduced fertility, but their risk for 
delayed conception is significantly higher than women who do not smoke.14,15 Scholars also 
warn of heightened risks of pregnancy complications for women smoking during pregnancy.1 
These include but are not limited to placental abruption, anemia, chronic hypertension, and 
placenta previa.1  
 In addition to pregnancy complications, risks to the fetus include low birth weight, 
preterm birth, restricted growth, stillbirth, and sudden infant death syndrome (SIDS).1 Maternal 
smoking during pregnancy is attributed to an estimated 5-8% of preterm births, 13-19% of 
infants with low birth weight, 5-7% to preterm related deaths, and 23-24% of SIDS cases.16 In 
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fact, infants born to women who smoke during pregnancy are 1.4 to 3 times more likely to die 
from SIDS than infants born to non-smokers.15 Exposure to perinatal smoking also increases 
infants’ risk for impaired lung growth, otitis media, necrotizing enterocolitis, severe asthma, and 
infectious disease.1 Secondhand smoke exacerbates these conditions, increasing risk of 
respiratory infections and ear infections.1 Finally, a 2011 systematic review notes that perinatal 
tobacco use is positively associated with congenital malformations, such as heart, 
musculoskeletal system, and limb reduction defects.17 Such smoking-related malformations are 
estimated to have cost the United States $46 million in healthcare expenses.17  
 Cessation of perinatal tobacco use is not only key to improving maternal and child health 
outcomes and other health outcomes throughout the life course, but it also produces cost savings. 
For instance, the United States spends nearly $122 million per year ($279 per maternal smoker) 
in neonatal health care costs alone.18-19 By creating interventions to help women to quit, 
approximately $6 would be saved per dollar invested in a prenatal tobacco cessation program20, 
$4,000 saved for every low birth weight baby prevented21, $63,000 for every perinatal death 
prevention21, and $210,000 per SIDS case prevented.22 Furthermore, by eliminating perinatal 
tobacco use, it could reduce all infant deaths by 10% and reduce deaths from perinatal conditions 
by 12%.14    
Perinatal Smoking Cessation: Interventions & Behavioral Strategies  
 In order to reduce perinatal smoking among women of reproductive age (15-44 years) in 
the United States, there are several evidence-based interventions and behavior strategies that can 
be employed. These interventions are put in place to help reduce the health risks to both mother 
and infant. While there are proven and effective comprehensive tobacco-control strategies, such 
as cigarette taxes and 100% smoke-free policies, which help reduce smoking prevalence around 
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the time of pregnancy, this review will focus on clinical interventions targeted toward smoking 
women of reproductive age during the most critical periods: preconception, prenatal, and 
postpartum.  
PRECONCEPTION PERIOD  
 According to the Centers for Disease Control and Prevention (CDC), preconception 
health care is defined as “a set of interventions that aim to identify and modify biomedical, 
behavioral, and social risks to a woman's health or pregnancy outcome through prevention and 
management.”9 Since individuals have unique health needs, preconception care is different for 
every person and can include men, women and couples of reproductive age.9  For optimal 
maternal and infant health outcomes, preconception care would ideally begin before a woman’s 
first pregnancy.9 Interventions during this time period help address risks to pregnancy, with the 
aim of eliminating these risks before conception occurs.23 Preconception is important because it 
allows clinicians and providers an opportunity to assess and treat tobacco use before pregnancy, 
decreasing the likelihood of poor maternal and infant outcomes.23 
 Research indicates the counseling to quit during this preconception period is critical, as 
15%-42% of women will quit smoking before initiating prenatal care.24 Patricia Mullen notes 
that women of lower socioeconomic status are less likely to quit smoking before prenatal care; 
however, for every 5-15 minutes of counseling delivered by a trained professional, cessation 
rates increase by an average of 6-7 percentage points.24 One such counseling option is referred to 
as cognitive behavioral therapy, or CBT. CBT is designed to address the attitudes and beliefs 
about smoking and quitting with the aim of replacing those behaviors with healthier behaviors. 
The main components of CBT are skills training, cognitive training, and lifestyle rebalancing.25 
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Each of these components is meant to develop coping techniques, self-efficacy and alternative 
thinking or methods for relaxation.25  
 The CDC also recommends that clinicians use strong evidence-based guidelines when 
delivering counseling in preconception care visits. This includes the 5A’s.23The 5A’s is a five 
step approach recommended by the USPHS clinical practice guidelines for all smokers and 
consists of: ask, advise, assess, assist and arrange.23 The first step is to ask each patient about 
their tobacco use.23 If patients indicate that they smoke, clinicians should advise patients to quit 
and assess their willingness to quit. The fourth step is to arrange a follow up, and if necessary, 
assist with their cessation efforts.23 Assisting includes offering pharmacotherapies or additional 
counseling.23 By offering this additional assistance, quit rates have been shown to double in non-
pregnant women, with effectiveness increasing when the number of and length of sessions 
increases.23  
 As for FDA-approved medications, there are several available: bupropion, varenicline 
and nicotine replacement therapies, including the gum, patch, lozenge, inhaler, and nasal spray.23 
Due to the controversy surrounding safe use of pharmacotherapy in pregnancy, it is advised that 
clinicians offer these medications during the preconception period.23 For patients unwilling to 
quit tobacco, the USPHS clinical practice guidelines recommend the 5R’s: relevance, risks, 
rewards, roadblocks, and repetition.23 These steps aim to motivate patients by addressing why 
quitting smoking is relevant, identifying  the risks and benefits associated with smoking, 
identifying the barriers to quitting, and repeating motivational interviewing. 23, 25 Involving 
partners of future mothers is also important, as there is a strong association with partner smoking 
and relapse as well as secondhand smoke exposure.24 
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 In addition to providing counseling, the CDC recommends use of a reminder system and 
telephone quitlines to support the cessation process. Reminder systems alert or remind health 
care providers to advise smokers in their health care setting and may involve use of electronic 
medical records (EHR) or a sticker or notification of a patient’s smoking status.23 State quitlines 
are also an important and effective means for patients to receive counseling, in which a provider 
can refer tobacco users to their state quitline by calling 1-800-QUIT NOW. A majority of 
quitlines provide multiple sessions of counseling, a quit kit, and some state quitlines may even 
provide over-the-countermedications.23 Many quitlines have also developed special protocols and 
guidance for pregnant smokers.27 These protocols often involve more interventions and aim to 
address the increased social and economic instability that is common for many pregnant 
smokers.27 
 According to several studies, many women quit after learning they are pregnant. Quit 
rates may range from 11% to 28% for women with public insurance to 40% to 65% for women 
with private insurance.23 Thus, if tobacco cessation strategies and interventions were placed into 
preconception care and practice, scholars expect that cessation rates would exceed these current 
quit rates.23 
PRENATAL PERIOD 
 The prenatal period refers to the period of time between conception and birth.5 It is 
perhaps one of the most critical times for a woman to quit smoking.5 One of the best practices for 
smoking cessation in the prenatal period entails counseling, or CBT.5 Evidence-based 
approaches used in the preconception period, such as the 5A’s and 5R’s, are also recommended 
for counseling pregnant women. If behavioral approaches fail, the American College of 
Obstetricians and Gynecologists recommends nicotine replacement therapies (NRTs) during 
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pregnancy.5 According to a systematic review of approximately 111 randomized clinic trails, 
NRTs may increase a smoker’s chance of quitting by 50% to 70%.25 However, the safety and 
efficacy of NRTs are not clearly known, as clinical trials using NRTs on pregnant women were 
inconclusive.25 Scholars argue that NRTs effects were seen as inconclusive because pregnant 
women metabolize nicotine and cotinine 60% to 140% faster than non-pregnant smokers.25 
Nevertheless, the FDA recommends caution when administrating such drugs.5 
 Overall, evidence strongly indicates that a multicomponent approach must be used when 
providing tobacco cessation interventions to pregnant women.25 According to Pollak et al., 
cessation rates during pregnancy were almost three times higher in women who had received a 
combination of CBT and NRTs than women who had just received CBT.26 While NRTs are 
considered to be safer for pregnant woman than either bupropion SR or varenicline, effects on 
the fetus are unknown 25 
 Scholars have also indicated cessation success in the prenatal period through financial 
incentives, indicating a quit rate of up to 34% in the intervention group and improvements in 
infant birth weight.5 However, such financial incentives must be further researched to determine 
cost effectiveness as well as to determine effectiveness in more diverse populations and settings.5 
Other studies have looked at voucher based reinforcement therapy (VBRT) as an incentive for 
smoking cessation.28 VRBT is therapy in which pregnant smokers are able to earn vouchers for 
retail items once their abstinence from tobacco use is verified using biochemical tests.28 Heil et 
al. found that these type of contingent vouchers are successful in increasing smoking cessation 
compared to non-contingent vouchers (41% vs. 10%) at the end of the pregnancy.28 Despite its 
success, Heil et al. notes the need for interventions of lower intensity, lower costs and greater 
reach.28 
16 
 
POSTPARTUM PERIOD  
 Postpartum refers to the period of time directly following birth to approximately 6 weeks 
after birth.29 This 6th week mark has traditionally been defined as women’s transition from 
pregnant to non-parous status.30 For women who did not quit smoking during pregnancy, there 
are very few who quit postpartum. For those who do quit, their reason for quitting is often related 
to the effects of secondhand smoke exposure.31 This postpartum period is also a time marked 
when both intervention assisted quitters and spontaneous quitters, women who quit immediately 
upon learning they are pregnant, are likely to relapse.31 Researchers estimate that as many as 
70% of women who quit during pregnancy return to smoking within 6 months after delivery.31 
 Remarkably, research indicates that relapse is often postponed until after mothers wean 
their infants from breastfeeding.32 Yet, further research with larger sample sizes is needed to 
explore factors to explain this association, as studies have shown that pregnant women who 
smoke are less likely to intend to breastfeed, less likely to initiate breastfeeding, and likely to 
breastfeed for a shorter duration than nonsmoking pregnant women.32-33 In fact, mothers who 
return to smoking postpartum are 50 percent more likely to wean their infants from breastfeeding 
early (less than 12 weeks).32 This is compared to mothers who abstained from smoking 
postpartum.32  However, despite several studies indicating a dose-response relationship between 
the number of cigarettes smoked per day and breastfeeding intention, initiation and duration, 
national breastfeeding rates for this population have not yet been aggregated.32-33 Nevertheless, 
current evidence suggests the need for integration of smoking relapse prevention and 
breastfeeding promotion.32 Unfortunately, there are far fewer tobacco cessation interventions that 
target this unique transition into motherhood, which is often marked by stress, lack of sleep, and 
concerns about weight.31 
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 One intervention, referred to as Project PANDA, specifically targeted this unique and 
vulnerable time period by mailing resources to women and their partners who smoked during the 
pregnancy period.30 These materials were mailed in the last few weeks of a woman’s pregnancy 
and the first six weeks postpartum.30 Items mailed include videos and newsletters about smoking 
cessation.30 According to the study, intervention participants showed greater abstinence (55% vs 
45%) during the follow-up period as well as at the one-year mark, showing promise that 
permanent abstinence is possible.30 This study’s success was partly due to its focus on the role of 
partner, in which the partner received tailored videos and materials. An early evaluation of these 
materials showed greater cessation among the men.30 
CHALLENGES 
 There are several barriers to successfully employing perinatal tobacco cessation in clinic 
and healthcare settings. Despite evidence suggesting tobacco cessation interventions are more 
successful when delivered by health care providers, providers face implementation challenges 
and many may be reluctant to provide these interventions.25 These barriers include lack of time, 
inadequate training or institutional support, limited resources, and competing priorities.25 Some 
providers simply believe that patients cannot and will not quit. As a result, patients receive 
minimal tobacco cessation counseling (3-5 minutes) and of the 56% of health care providers 
trained on smoking cessation, only 35% provided patients with self-help materials.25  
 Yet, these challenges are not insurmountable, as S.M.A.R.T. Moms, or Smart Mothers 
Are Resisting Tobacco, illustrated in Tennessee where 29.3% of all pregnant WIC patients 
smoked.34 S.M.A.R.T Moms is a Tennessee-based project that designed a self-help guide to 
educate pregnant WIC mothers on the dangers of smoking.34 The self-help guide, which was 
based on the 5A’s, was used by trained providers in all WIC clinics in Tennessee.34 By providing 
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comprehensive training for the health care providers, S.M.A.R.T Moms discovered that of the 
13,285 patients receiving counseling and smoking cessation resources, 77% percent of women 
who received the self-help guide and counseling agreed to attempt smoking cessation.34 Of those 
women, 24.4% quit smoking, which exceeds prior success rates of 14%  in similar settings.34 The 
project also addressed challenges noted by health care providers, such as lack of time and 
training. It not only provided training on evidence-based counseling techniques that were short, 
simple and brief, but the project also provided patient resources and incentives for patients and 
providers.34As a result of the project’s success, its activities are now institutionalized in the state 
government system.34 
Rationale for Tools  
 As evidenced by the review of interventions for perinatal smoking cessation, there are 
numerous resources and strategies that can be used by clinicians, health care providers, and 
public health professionals to help clients quit smoking, once and for all. In identifying best 
practices and gaps in implementation, tools were created for clinicians in inpatient and outpatient 
clinical settings. These tools can be accessed through Prevention Partners’ Patient Quit Tobacco 
System, one of four nationally recognized web-based products helping to effectively promote 
tobacco cessation for patients in hospital and clinics. Prevention Partners is a nonprofit located in 
Chapel Hill, North Carolina that focuses on addressing the nation’s leading health issues, 
including decreasing tobacco use, increasing physical activity, promoting good nutrition and 
reducing obesity. To review the developed tools, please refer to the Appendix.  
Conclusion 
  The association between adverse maternal and infant health outcomes and tobacco use 
before, during and after pregnancy has been well documented. With the recently passed 
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Affordable Care Act (ACA), which requires all Medicaid programs to cover a comprehensive 
tobacco cessation benefit for pregnant women, there have been significant changes to prevention 
in healthcare.5 While more extensive coverage for cessation interventions will improve prenatal 
and postpartum quit rates, the need to address tobacco use through preconception care and 
primary care prevention continues to grow.23 In fact, scholars believe cessation rates would 
exceed current pregnancy quit rates if tobacco cessation strategies and interventions were placed 
into preconception care and practice.23 
   However, there are several challenges for preconception care, as preconception health 
and health care is a relatively new paradigm that healthcare providers are still working to 
actively promote and integrate within services.35 One challenge is family planning. While ideally 
health care providers should assist female smokers of reproductive age to quit smoking before 
conceiving, nearly half of all pregnancies in the United States are unintended.35 Having an 
unintended pregnancy often affects prenatal outcomes, as pregnant women who smoke are less 
likely to obtain prenatal care and more likely to start prenatal care later than nonsmoking 
women.5   
 While pregnancy may serve as an opportunity for women to change their patterns of 
tobacco use, many of these women are facing far superior battles than their fight to quit 
tobacco.10 Thus, greater efforts should be placed on acknowledging social and structural factors 
affecting both pregnant and non-pregnant female smokers and integrating a social determinants 
framework into primary care prevention and cessation interventions.  Current research suggests 
that electronic medical records and their multiple functions, including screening, triaging, 
referring, tracking, and data sharing, may serve as a platform for such integration.36 The Institute 
of Medicine plans to publish recommendations on the facilitation of incorporating evidence-
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based social determinants of health metrics into healthcare delivery systems, which could 
enhance the integration of medical care and social services.36 By focusing on prevention before 
pregnancy rather than treatment, there is an opportunity to advance preconception care and 
improve the landscape of maternal and perinatal health.  
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